<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0662-0001-99
</NDCCode>
<PackageDescription>
10 TRAY in 1 CASE (0662-0001-99) / 10 CARTON in 1 TRAY (0662-0001-10) / 1 VIAL in 1 CARTON (0662-0001-01) / 20 mL in 1 VIAL (0662-0001-20)
</PackageDescription>
<NDC11Code>
00662-0001-99
</NDC11Code>
<ProductNDC>
0662-0001
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Lidocaine Hydrochloride And Epinephrine
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20191010
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Hospira, Inc.
</LabelerName>
<SubstanceName>
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
10; 20
</StrengthNumber>
<StrengthUnit>
ug/mL; mg/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-04-15
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
10-OCT-19
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>